Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia.

Date publication

janvier 2017

Journal

European journal of haematology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr LAROSA Fabrice , Dr LIOURE Bruno , Dr OJEDA-URIBE Mario

Tous les auteurs :
Cahu X, Carré M, Recher C, Pigneux A, Hunault-Berger M, Vey N, Chevallier P, Delaunay J, Gyan E, Lioure B, Bonmati C, Himberlin C, Hicheri Y, Guillerm G, Didier B, Larosa F, Ojeda-Uribe M, Bernard M, Bene MC, Ifrah N, Cahn JY

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28122150

Résumé

Anthracyclines and cytarabine are cornerstones for intensive chemotherapy in acute myeloid leukemia (AML). The goals of this study were to comprehensively assess deviations from theoretical doses and the impact of body-surface area (BSA) on patients' characteristics, physicians' strategy, dose adjustment, and clinical outcome.

Référence

Eur. J. Haematol.. 2017 Jan;: